Quantcast

Latest autoimmune diseases Stories

2014-07-07 11:39:51

European League Against Rheumatism Slower dose tapering and absence of positive serology reduce risk of flare A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that, for the majority of lupus patients who are in remission, it is possible to successfully stop immunosuppressant therapy without triggering a flare of their disease. Within two years, it was possible to stop the immunosuppressant in about 70% of clinically stable...

early celiac sign
2014-07-04 03:30:55

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH-funded study finds higher celiac risk in Sweden than US, elsewhere More than one quarter of children with two copies of a high-risk variant in a specific group of genes develop an early sign of celiac disease called celiac disease autoimmunity (CDA) by age 5. The findings are from The Environmental Determinants of Diabetes in Youth consortium, or TEDDY. The National Institutes of Health-funded study, published July...

2014-07-03 23:08:35

World Vitiligo Day 2014 promises to be the biggest yet, with a vast array of awareness and support events spanning the globe. Sponsored by the New York based Vitiligo Research Foundation, this years festivities will be based in Chandigarh, India. New York City, Now York (PRWEB) July 03, 2014 World Vitiligo Day day was Inaugurated in 2011 as a grassroots advocacy project to bring the plight of the approximately 100 million sufferers worldwide into the spotlight. As perhaps the world most...

2014-07-03 08:23:49

MUMBAI,India, July 3, 2014 /PRNewswire/ -- - GBR 830 is an antagonistic monoclonal antibody with first in class potential for the treatment of autoimmune diseases targeting OX40, a co-stimulatory receptor on T cells - The antibody has successfully completed the Phase I enabling preclinical development program and a Phase I clinical trial application has been filed with The Netherlands authorities -...

2014-07-03 08:23:24

- Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union BRUSSELS and REDWOOD CITY, Calif., July 3, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical leader (Euronext: UCB), and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia(®) (certolizumab pegol) in dermatology. This collaboration aims...

2014-07-03 04:21:19

VIENNA, July 3, 2014 /PRNewswire/ -- Debilitating daily symptoms of Inflammatory Bowel Disease (IBD) not only cause depression and psychological complications in young people, but also significantly disrupts their education and ability to stay at work. In response to a new study highlighting the impact of IBD on children, United European Gastroenterology (UEG), Europe's largest digestive health body, is calling for quicker diagnosis and treatment to minimise the impact IBD has...

2014-07-01 23:09:21

Brought to her knees and nearly her death by ulcerative colitis, 25 year old Karin Miller was given a second chance at life thanks to a life-saving surgery. Miller used her second chance to help others with her newly launched website NewbieOstomy. (PRWEB) July 01, 2014 Ulcerative Colitis (UC) is a common inflammatory bowel disease (IBD) which affects the top layers of the colon. Left untreated, it can increase the risk of colon cancer. According to the Centers for Disease Control and...

2014-06-29 23:00:34

DailyGossip.org publishes a useful review to the Natural Multiple Sclerosis Cure program to help patients find a way to feel better and eliminate symptoms Denver, Colorado (PRWEB) June 29, 2014 In its newly published review, Daily Gossip Magazine reveals that multiple sclerosis actually is commonly described as one of the most debilitating and discouraging conditions that patients can be diagnosed with. The author of the Natural Multiple Sclerosis Cure claims to know that perfectly well,...

2014-06-26 12:29:42

LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Multiple Sclerosis -- KOL Insight and Consensus Outlook Moduleshttp://www.reportbuyer.com/pharma_healthcare/diseases/multiple_sclerosis_kol_insight_consensus_outlook_modules.html IntroductionThe multiple sclerosis treatment landscape has undergone dramatic changes over the past year. Biogen's Tecfidera has revolutionised multiple sclerosis treatment in the U.S., eroding significant market...

2014-06-26 08:28:32

NPF Psoriatic Arthritis Project to improve diagnosis, care and treatment for millions PORTLAND, Ore., June 26, 2014 /PRNewswire-USNewswire/ -- Millions of Americans with psoriatic arthritis--a serious disease that causes pain, swelling and stiffness of the joints and tendons, and can result in joint damage if left untreated--struggle to get the health care and treatments they need to manage their condition. National Psoriasis Foundation plans to change that by launching the largest...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related